Literature DB >> 17325744

Impact of stroma on the growth, microcirculation, and metabolism of experimental prostate tumors.

Christian M Zechmann1, Eva C Woenne, Gunnar Brix, Nicole Radzwill, Martin Ilg, Peter Bachert, Peter Peschke, Stefan Kirsch, Hans-Ulrich Kauczor, Stefan Delorme, Wolfhard Semmler, Fabian Kiessling.   

Abstract

In prostate cancers (PCa), the formation of malignant stroma may substantially influence tumor phenotype and aggressiveness. Thus, the impact of the orthotopic and subcutaneous implantations of hormone-sensitive (H), hormone-insensitive (HI), and anaplastic (AT1) Dunning PCa in rats on growth, microcirculation, and metabolism was investigated. For this purpose, dynamic contrast-enhanced magnetic resonance imaging and (1)H magnetic resonance spectroscopy ([(1)H]MRS) were applied in combination with histology. Consistent observations revealed that orthotopic H tumors grew significantly slower compared to subcutaneous ones, whereas the growth of HI and AT1 tumors was comparable at both locations. Histologic analysis indicated that glandular differentiation and a close interaction of tumor cells and smooth muscle cells (SMC) were associated with slow tumor growth. Furthermore, there was a significantly lower SMC density in subcutaneous H tumors than in orthotopic H tumors. Perfusion was observed to be significantly lower in orthotopic H tumors than in subcutaneous H tumors. Regional blood volume and permeability-surface area product showed no significant differences between tumor models and their implantation sites. Differences in growth between subcutaneous and orthotopic H tumors can be attributed to tumor-stroma interaction and perfusion. Here, SMC, may stabilize glandular structures and contribute to the maintenance of differentiated phenotype.

Entities:  

Mesh:

Year:  2007        PMID: 17325744      PMCID: PMC1803035          DOI: 10.1593/neo.06688

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  59 in total

Review 1.  Molecular regulation of vessel maturation.

Authors:  Rakesh K Jain
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

Review 2.  Prostate cancer.

Authors:  William G Nelson; Angelo M De Marzo; William B Isaacs
Journal:  N Engl J Med       Date:  2003-07-24       Impact factor: 91.245

3.  Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment.

Authors:  S K Hobbs; W L Monsky; F Yuan; W G Roberts; L Griffith; V P Torchilin; R K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

4.  Dynamic T1-weighted monitoring of vascularization in human carcinoma heterotransplants by magnetic resonance imaging.

Authors:  Fabian Kiessling; Melanie Heilmann; Silvia Vosseler; Matthias Lichy; Martin Krix; Christian Fink; Isabel Kiessling; Heinrich Steinbauer; Lothar Schad; Norbert E Fusenig; Stefan Delorme
Journal:  Int J Cancer       Date:  2003-03-10       Impact factor: 7.396

5.  Viable circulating metastatic cells produced in orthotopic but not ectopic prostate cancer models.

Authors:  Anna B Glinskii; Brian A Smith; Ping Jiang; Xiao-Ming Li; Meng Yang; Robert M Hoffman; Gennadi V Glinsky
Journal:  Cancer Res       Date:  2003-07-15       Impact factor: 12.701

6.  Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.

Authors:  Ruth Etzioni; David F Penson; Julie M Legler; Dante di Tommaso; Rob Boer; Peter H Gann; Eric J Feuer
Journal:  J Natl Cancer Inst       Date:  2002-07-03       Impact factor: 13.506

Review 7.  Role of stroma in carcinogenesis of the prostate.

Authors:  Gerald R Cunha; Simon W Hayward; Y Z Wang
Journal:  Differentiation       Date:  2002-12       Impact factor: 3.880

8.  Microcirculation and microvasculature in breast tumors: pharmacokinetic analysis of dynamic MR image series.

Authors:  Gunnar Brix; Fabian Kiessling; Robert Lucht; Susanne Darai; Klaus Wasser; Stefan Delorme; Jürgen Griebel
Journal:  Magn Reson Med       Date:  2004-08       Impact factor: 4.668

9.  Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.

Authors:  Mukesh G Harisinghani; Jelle Barentsz; Peter F Hahn; Willem M Deserno; Shahin Tabatabaei; Christine Hulsbergen van de Kaa; Jean de la Rosette; Ralph Weissleder
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

10.  Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens?

Authors:  Heinz-Peter Schlemmer; Jonas Merkle; Rainer Grobholz; Tim Jaeger; Maurice Stephan Michel; Axel Werner; Jan Rabe; Gerhard van Kaick
Journal:  Eur Radiol       Date:  2003-10-03       Impact factor: 5.315

View more
  14 in total

1.  A surgical orthotopic organoid transplantation approach in mice to visualize and study colorectal cancer progression.

Authors:  Arianna Fumagalli; Saskia J E Suijkerbuijk; Harry Begthel; Evelyne Beerling; Koen C Oost; Hugo J Snippert; Jacco van Rheenen; Jarno Drost
Journal:  Nat Protoc       Date:  2018-01-04       Impact factor: 13.491

Review 2.  How can grafted breast cancer models be optimized?

Authors:  Séverine Mollard; Yoanne Mousseau; Yasser Baaj; Laurence Richard; Jeanne Cook-Moreau; Jacques Monteil; Benoît Funalot; Franck G Sturtz
Journal:  Cancer Biol Ther       Date:  2011-11-15       Impact factor: 4.742

3.  Assessment of the early effects of 5,6-dimethylxanthenone-4-acetic acid using macromolecular contrast media-enhanced magnetic resonance imaging: ectopic versus orthotopic tumors.

Authors:  Mukund Seshadri; David A Bellnier; Richard T Cheney
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-11-15       Impact factor: 7.038

4.  The War on Cancer rages on.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

5.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

6.  Noninvasive multiparametric imaging of metastasis-permissive microenvironments in a human prostate cancer xenograft.

Authors:  Marie-France Penet; Arvind P Pathak; Venu Raman; Paloma Ballesteros; Dmitri Artemov; Zaver M Bhujwalla
Journal:  Cancer Res       Date:  2009-10-27       Impact factor: 12.701

7.  High dose rate radiation treatment of experimental intramuscular prostate carcinoma.

Authors:  Christina Skourou; P Jack Hoopes; Summer L Gibbs-Strauss; David J Gladstone; Rendall Strawbridge; Keith D Paulsen
Journal:  Int J Radiat Biol       Date:  2009-04       Impact factor: 2.694

8.  Epithelial and mesenchymal tumor compartments exhibit in vivo complementary patterns of vascular perfusion and glucose metabolism.

Authors:  Mirco Galiè; Paolo Farace; Cristina Nanni; Antonello Spinelli; Elena Nicolato; Federico Boschi; Paolo Magnani; Silvia Trespidi; Valentina Ambrosini; Stefano Fanti; Flavia Merigo; Francesco Osculati; Pasquina Marzola; Andrea Sbarbati
Journal:  Neoplasia       Date:  2007-11       Impact factor: 5.715

9.  Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells.

Authors:  Danilo Millimaggi; Marianna Mari; Sandra D'Ascenzo; Eleonora Carosa; Emmanuele Angelo Jannini; Stanley Zucker; Gaspare Carta; Antonio Pavan; Vincenza Dolo
Journal:  Neoplasia       Date:  2007-04       Impact factor: 5.715

10.  Dynamic oxygen challenge evaluated by NMR T1 and T2*--insights into tumor oxygenation.

Authors:  Dawen Zhao; Jesús Pacheco-Torres; Rami R Hallac; Derek White; Peter Peschke; Sebastian Cerdán; Ralph P Mason
Journal:  NMR Biomed       Date:  2015-06-08       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.